Clinical trials
Phase 2 Lupus Erythematosus, Systemic trials in Peru
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2023 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Terminated | 4 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| MedImmune LLC | 3 |
| Anthera Pharmaceuticals | 2 |
| EMD Serono | 2 |
| GlaxoSmithKline | 2 |
| Ablynx, a Sanofi company | 1 |
| Alumis Inc | 1 |
| AstraZeneca | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Lakefront Biotherapeutics NV | 1 |
| Neovacs | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lupus Erythematosus, Systemic | 17 |
| Autoimmune Diseases | 3 |
| Connective Tissue Diseases | 1 |
| Immune System Diseases | 1 |
| Mycobacterium Infections, Nontuberculous | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.